InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Schneider Jerry A., Director. Director active across 1 company, notably Kiromic Biopharma, Inc.. Cumulatively, 2 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €60k. History available since 24 May 2021. The latest transaction was filed on 24 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
5,000 shares@ US$7.3150.0% of flowCommon StockSEC:0001104659-21-072372:0
Ideal exit: 18 Feb 2022 (T+270)
5,000 shares@ US$7.3150.0% of flowCommon StockSEC:0001104659-21-072372
Ideal exit: 18 Feb 2022 (T+270)
2 of 2 declarations
About Schneider Jerry A.
Jerry A. Schneider is a Director at Kiromic Biopharma, Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Kiromic.
